ZYGFLOVIPriority claimed from 16/01/2024; Application No. : 98359121 ;United States of America (Class 5)
#6526137
Application Number:6526137
Status:
DRAFT
Class:5
Applicant: Direct Biologics LLC
Filing Date:Mon, 15 Jul 2024
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | ZYGFLOVIPriority claimed from 16/01/2024; Application No. : 98359121 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 6526137 |
| Nature/Scope of business | Pharmaceutical preparations based upon human allogeneic bone marrow mesenchymal stem cell derived extracellular vesicles (EVs) containing secretomes for the treatment of immunomodulatory, inflammatory, or autoimmune conditions such as respiratory diseases, neurological diseases, tissue injury and repair, gastrointestinal diseases, joint diseases and transplant. |
| Publication | In Journal No. 2251 |
| Status | DRAFT |
| Applicant: | Direct Biologics LLC |
| Applicant Address | 5301 Southwest Parkway, Bldg 1, Ste 415 Austin, TEXAS UNITED STATES 78735 A Wyoming Limited Liability Company |
| Jurisdiction | DELHI |
| Agent | FIDUS LAW CHAMBERS |
| Agent Address | Flat No. 021, Mahagun Maestro Plot No. F21A Sector 50 Noida - 201301 |
Frequently Asked Questions
What is the status of trademark ZYGFLOVIPriority claimed from 16/01/2024; Application No. : 98359121 ;United States of America? ▾
The trademark application number 6526137 is currently marked as "DRAFT" in the official trademark registry.
Who is the owner of trademark ZYGFLOVIPriority claimed from 16/01/2024; Application No. : 98359121 ;United States of America? ▾
The trademark application number 6526137 is owned by Direct Biologics LLC.
Which class does trademark ZYGFLOVIPriority claimed from 16/01/2024; Application No. : 98359121 ;United States of America belong to? ▾
Trademark application number 6526137 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 6526137? ▾
The trademark agent associated with application number 6526137 is FIDUS LAW CHAMBERS.
Was trademark ZYGFLOVIPriority claimed from 16/01/2024; Application No. : 98359121 ;United States of America published in the journal? ▾
Yes, trademark application number 6526137 was published in Journal No. 2251.
What is trademark ZYGFLOVIPriority claimed from 16/01/2024; Application No. : 98359121 ;United States of America? ▾
Trademark application number 6526137 relates to "Pharmaceutical preparations based upon human allogeneic bone marrow mesenchymal stem cell derived extracellular vesicles (EVs) containing secretomes for the treatment of immunomodulatory, inflammatory, or autoimmune conditions such as respiratory diseases, neurological diseases, tissue injury and repair, gastrointestinal diseases, joint diseases and transplant.".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified